Neuroimaging Findings in Pediatric Patients with Thalassemia Major

Cranial magnetic resonance imaging (MRI) studies about iron accumulation in children with thalassemia major are quite limited. This study aimed to detect neurological findings with cranial MRIs in the pediatric patients with thalassemia major who did not develop any neurological complications. Pedia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematology reports 2022-03, Vol.14 (1), p.54-60
Hauptverfasser: Akbaş, Yılmaz, Aydın, Sultan, Tunçer, Gökçen Öz, Köker, Alper, Çoban, Yasemin, Oktay, Gönül, Yeral, Hakan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cranial magnetic resonance imaging (MRI) studies about iron accumulation in children with thalassemia major are quite limited. This study aimed to detect neurological findings with cranial MRIs in the pediatric patients with thalassemia major who did not develop any neurological complications. Pediatric patients with thalassemia major who followed in the Pediatric Hematology Unit between 1 July 2017 and 1 January 2019 were included in the study. The patients underwent cranial MRI scans. A total of 30 patients were included. The median age was 15 (range from 4-18) years old. We found that 7 patients had a splenectomy and 19 of the remaining 23 patients had splenomegaly. In addition, 13 of the patients had hepatomegaly, 10 had skeletal deformities, and 17 had growth retardation. The mean ferritin level was 3772.3 ± 2524.8. We detected various pathologies on cranial MRI images of 10 (33.3%) patients. In 3 of these patients, millimeter-sized ischemia-compatible lesions were found in the cerebral white matter, which did not fit any arterial area, and 5 patients had hyperintense lesions in the basal ganglia. Our study is valuable since 1/3 of our pediatric patients with thalassemia major were detected with intracranial pathology.
ISSN:2038-8322
2038-8330
2038-8330
DOI:10.3390/hematolrep14010009